Is sitaxsentan a safe and efficacious treatment for pulmonary arterial hypertension?

Affiliations

Comment

Marius M Hoeper. Nat Clin Pract Cardiovasc Med. 2006 Oct.

. 2006 Oct;3(10):536-7.

doi: 10.1038/ncpcardio0675.

¹ Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany. hoeper.marius@mh-hannover.de

No abstract available

Comment on

Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.
Barst RJ, Langleben D, Badesch D, Frost A, Lawrence EC, Shapiro S, Naeije R, Galie N; STRIDE-2 Study Group. Barst RJ, et al. J Am Coll Cardiol. 2006 May 16;47(10):2049-56. doi: 10.1016/j.jacc.2006.01.057. Epub 2006 Apr 24. J Am Coll Cardiol. 2006. PMID: 16697324 Clinical Trial.